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Abstract
Since Alzheimer’s disease may affect driving performance, patients with Alzheimer’s disease are assessed on fitness to drive. 
On-road driving assessments are widely used, and attempts have also been made to develop strategies to assess fitness to 
drive in a clinical setting. Preferably, a first indication of fitness to drive is obtained quickly after diagnosis using a single 
test such as the Mini-Mental State Examination (MMSE). The aim of this study is to investigate whether the MMSE can 
be used to predict whether patients with Alzheimer’s disease will pass or fail an on-road driving assessment. Patients with 
Alzheimer’s disease (n = 81) participated in a comprehensive fitness-to-drive assessment which included the MMSE as well 
as an on-road driving assessment [PLoS One 11(2):e0149566, 2016]. MMSE cutoffs were applied as suggested by Versijpt 
and colleagues [Acta Neurol Belg 117(4):811–819, 2017]. All patients with Alzheimer’s disease who scored below the lower 
cutoff (MMSE ≤ 19) failed the on-road driving assessment. However, a third of the patients with Alzheimer’s disease who 
scored above the upper cutoff (MMSE ≥ 25) failed the on-road driving assessment as well. We conclude that the MMSE 
alone has insufficient predictive value to correctly identify fitness to drive in patients with very mild-to-mild Alzheimer’s 
disease implicating the need for comprehensive assessments to determine fitness to drive in a clinical setting.
Keywords Alzheimer’s dementia · Fitness to drive · Driving · MMSE
Introduction
In an ageing society, the number of patients with Alzhei-
mer’s disease (AD) is increasing [1], and many of them drive 
a car when they receive their diagnosis. Continuation of 
driving after diagnosis is common [2, 3], and can be safe in 
the early stages of AD [4, 5]. However, with disease progres-
sion, driving performance will decline. Accordingly, there 
is consensus that patients with moderate-to-severe dementia 
should not drive anymore [4]. For patients with very mild-to-
mild AD, individual assessments are necessary to determine 
their fitness to drive [6].
Despite the influence of AD on driving, the Belgian law 
on driving is rather vague in its referral to and instructions 
for AD, and does not implicate referral to an on-road driving 
assessment for all drivers with mild AD [7]. In The Nether-
lands, drivers who receive a diagnosis of AD have a moral 
obligation to report their diagnosis to the Dutch driving 
licence authority (CBR) [8]. Patients with very mild-to-mild 
AD (Clinical Dementia Rating < 2) are invited for an on-
road driving assessment of approximately 45 min. CBR uses 
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a protocol for patients with cognitive impairment to judge 
the driving performance of the patients. During the on-road 
driving assessment, patients drive in their own car with an 
expert of CBR in the passenger seat. CBR experts have long-
lasting experience with on-road examinations and are trained 
to observe the effects of diseases on driving performance.
The major advantage of on-road driving assessments is 
the high validity, i.e., patients drive in the real world, but 
there are also disadvantages. On-road driving assessments 
are relatively costly, as compared to most neuropsychologi-
cal tests. In addition, there is always a time gap between 
the clinical diagnosis and the on-road driving assessment. 
Patients may not report their diagnosis to the CBR instantly, 
and when they do it often takes several months until the 
on-road driving assessment is realised. Due to the rising 
number of patients with AD, it becomes increasingly dif-
ficult to assess all patients on the road early after diagnosis 
[9]. Meanwhile, it remains unclear whether patients with 
very mild-to-mild AD are safe to drive or not. On one hand, 
patients with AD have an increased accident risk [10] and 
should abstain from driving until their fitness to drive is 
determined. On the other hand, driving continuation serves 
the mobility needs of the patients with AD and having only 
limited recent driving experience decreases their chances of 
passing the on-road driving assessment [11].
Physicians diagnosing AD have to inform the patients 
about possible consequences for driving. Unsurprisingly, 
patients with AD and their family members often consult 
the treating physician for advice regarding driving [12], 
although physicians are usually not sufficiently equipped 
with proper tools to evaluate fitness to drive [6]. Unless 
available clinical tools could be used for this purpose, i.e., 
Versijpt and colleagues [7] recently suggested a framework 
using the Mini-Mental State Examination (MMSE) [13] as 
a starting point.
The MMSE is a screening instrument to acquire a global 
impression of cognitive functioning of a patient, and it is 
also used to stage the severity of AD [14]. The MMSE is 
easy to apply, because it can be administered with only little 
training, requires no technical or expensive equipment, and 
can be completed within 5–10 min. Patients with AD have to 
respond to verbally administered questions and instructions. 
The MMSE taps into various cognitive domains, including 
orientation, memory, and language. Since the MMSE is a 
short screening, cognitive domains of visuospatial abilities 
and executive functions are only assessed superficially [14, 
15]. In brief, the MMSE is a practical, commonly used clini-
cal tool, to assess global cognition.
The MMSE has also been used in studies about fitness 
to drive [6, 11, 16], in which a lower total MMSE score 
(range 0–30) was associated with a worse driving perfor-
mance. Despite this association, research has shown repeat-
edly that the MMSE is not a useful instrument in predicting 
driving performance in mixed dementia samples [6, 17, 18]. 
Recently, Versijpt and colleagues [7] proposed MMSE cut-
offs to trichotomize patients with AD specifically into tem-
porarily safe, indeterminate, and unsafe drivers. The authors 
emphasise that many other factors are important for driv-
ing, and a final decision on driving cessation should only be 
made after thorough risk assessment. Nonetheless, the first 
step in their proposed guideline is to let the clinician provide 
a temporary indication of fitness to drive early after a diag-
nosis of AD using MMSE cutoffs. The aim of the current 
study is to evaluate the MMSE as a valid indicator of fitness 
to drive in patients with AD by taking MMSE scores and 
on-road driving assessments from a comprehensive fitness-
to-drive assessment study [11]. MMSE cutoffs proposed by 
Versijpt and colleagues [7] will be used to classify patients 
with AD as safe or unsafe drivers. Patients with AD scoring 
below the lower cutoff (MMSE ≤ 19) are expected to fail 
the on-road driving assessment, whereas patients with AD 
scoring above the upper cutoff (MMSE ≥ 25) are expected 
to pass the on-road driving assessment.
Methods
Participants
Eighty-one patients with mild AD (Clinical Dementia Rat-
ing < 2) participated in this study. Their age ranged from 
52 to 91 years (M = 72 years; SD = 9 years), and 53 (65%) 
were men. All patients were in possession of a valid driving 
licence and had a wish to continue driving. AD was diag-
nosed by a neurologist, geriatrician, psychiatrist, or general 
practitioner. Ten patients were additionally diagnosed with 
vascular dementia (VaD). Exclusion criteria were the diag-
nosis of other neurological or psychiatric conditions that 
may influence driving performance and usage of medica-
tions with a severe influence on driving ability.
Measures
The MMSE [13, 19] is a screening instrument to acquire a 
global impression of cognitive functioning. It was adminis-
tered as the first instrument in a comprehensive fitness-to-
drive assessment in a clinical setting (see [11] for the full 
protocol). The sum score of the MMSE (range 0–30) was 
used.
The on-road driving assessment was performed in the 
patient’s own car on another day. These assessments were 
rated by approved experts on practical fitness to drive of 
CBR. They used a protocol for patients with cognitive 
impairments. Experts of CBR were blind to the patients’ 
MMSE scores. The CBR experts provided a pass, doubt-
ful, or fail outcome after each on-road driving assessment. 
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Patients with AD who passed the on-road driving assess-
ment are regarded safe drivers, while patients who failed 
the on-road driving assessment are regarded unsafe driv-
ers. The latter group would have lost their driving licence 
if their on-road driving assessment would have been part 
of an official relicensing procedure in The Netherlands. A 
doubtful outcome is not sufficient to renew a driving licence 
and is, therefore, regarded as a fail as well, but it indicates 
that it might be worthwhile to sign up for a second on-road 
driving assessment after adjusting the car (e.g., transition to 
automatic transmission) or additional driving lessons.
Statistical analysis
A receiver operating characteristic (ROC) analysis was car-
ried out to examine the accuracy of the MMSE in predict-
ing fitness to drive (i.e., passing/failing the on-road driv-
ing assessment) of patients with AD. An ROC curve was 
created by plotting the sensitivity against the specificity. A 
larger area under the curve (AUC) indicates better predic-
tive accuracy.
Patients with AD were trichotomized into three groups, 
i.e., unsafe, indeterminate, and safe, based on proposed 
MMSE cutoffs (≤ 19 and ≥ 25) [7]. The outcomes of the 
on-road driving assessments in these three groups were 
reported. Effects of adjustments of the MMSE cutoffs for 
the prediction of fitness to drive were described as well.
Results
MMSE scores of the patients with AD (n = 81) ranged from 
11 to 29 (M = 23.2, SD = 3.7). Thirty-five patients passed 
the on-road driving assessment, while 46 patients failed 
the on-road driving assessment (i.e., 41 fail and 5 doubt-
ful outcomes combined). An ROC analysis revealed that 
the MMSE was significantly predictive for fitness to drive 
of patients with AD, with moderate predictive accuracy 
(AUC = 0.762, SE = 0.052, p < .001).
Patients with AD were divided into three groups as sug-
gested by the MMSE cutoffs of Versijpt and colleagues 
[7] (Table 1). Thirteen patients had an MMSE score of 19 
or lower, and all these patients (10 with AD, 3 with AD 
and VaD) failed the on-road driving assessment (Table 2). 
Thirty-three patients with an MMSE score between 20 and 
24 were classified as indeterminate. Thirty-five patients had 
an MMSE score of 25 or higher, and 22 of them passed the 
on-road driving assessment (20 with AD, 2 with AD and 
Table 1  Characteristics of the 
three groups of patients with 
Alzheimer’s dementia divided 
based on MMSE cutoffs
Education, Verhage scale for the Dutch educational level ranging from 1 (primary school not finished) to 7 
(university level)
CDR score Clinical Dementia Rating total score, MMSE score Mini-Mental State Examination sum score 
(range 0–30)
a Data missing for one patient
b Data missing for two patients
Characteristics Group
MMSE ≤ 19 (n = 13) MMSE 20–24 
(n = 33)
MMSE ≥ 25 (n = 35)
Age [mean (SD)] (year) 76.9 (7.5) 71.9 (8.5) 69.7 (10.0)
Male sex [n (%)] 11 (84.6) 23 (69.7) 19 (54.3)
Education [mean of 7 stages (SD)] 4.1 (1.6) 4.9 (1.3) 5.2 (1.2)
CDR score [n (%)]
 0 0 (0.0%) 0 (0.0%) 1 (2.9)
 0.5 6 (46.2) 29 (87.9) 32 (91.4)
 1 7 (53.8) 4 (12.1) 2 (5.7)
MMSE score [mean (SD)] 16.9 (2.5) 22.2 (1.3) 26.4 (1.1)
Driving experience [mean (SD)] (y) 54.8 (8.1)a 50.2 (8.7) 46.3 (9.7)b
Table 2  Application of MMSE cutoffs to predict fitness to drive on 
the road
MMSE scores Mini-Mental State Examination sum scores (range 
0–30)
MMSE scores Classified as Pass rate on-road 
driving assess-
ment
≤ 19 Unsafe 0/13 (0%)
20–24 Indeterminate 13/33 (39%)
≥ 25 Safe 22/35 (63%)
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VaD), 2 had a doubtful outcome (2 with AD), and 11 failed 
the on-road driving assessment (9 with AD, 2 with AD and 
VaD). This means that only 63% of the patients with AD 
scoring above the upper MMSE cutoff could renew their 
driving licence.
Adjusting the lower MMSE cutoff to 20 or lower resulted 
in an accurate prediction of failing the on-road driving 
assessment as well (0/16 patients with AD passed). How-
ever, adjusting the upper MMSE cutoff to an MMSE score 
of 26 or 27 and higher does not result in a more accurate 
prediction of fitness to drive compared to a cutoff of 25. For 
patients with AD with an MMSE score of exactly 27, the 
chance of passing the on-road driving assessment was only 
50%. An even higher upper MMSE cutoff is not desirable, 
because the indeterminate group would become unreason-
ably large. Nonetheless, five out of the six patients with AD 
with an MMSE score of 28 or 29 passed the on-road driving 
assessment.
Discussion
The aim of the current study was to investigate whether the 
MMSE alone could be used to accurately predict fitness to 
drive of patients with very mild-to-mild AD. The total score 
of the MMSE was significantly predictive for the outcome of 
an on-road driving assessment. Moreover, the lower MMSE 
cutoff (≤ 19) proposed in a framework by Versijpt and col-
leagues [7] accurately classified patients with AD as unsafe 
drivers. However, the higher MMSE cutoff (≥ 25) classified 
only 63% of the patients with AD correctly as safe drivers.
In a recent paper [20], consensus was sought among cli-
nicians about various recommendations regarding driving 
and dementia. Clinicians agreed (> 90% agreement) that 
the MMSE and other tests have insufficient sensitivity or 
specificity to be used alone to determine fitness to drive in 
patients with dementia [20], which is in correspondence 
with the results from the current study and previous studies 
[6, 16, 18, 21]. Even though abnormal MMSE scores may 
indicate the need to further assess the driver at risk (> 90% 
agreement), clinicians did not fully agree (< 90% agreement) 
that substantial impairments as indicated by the MMSE, 
typically associated with moderate-to-severe dementia, 
may preclude safe driving. Various reasons were mentioned, 
including the lack of established cutoffs and the need to eval-
uate cognitive test scores in light of the full clinical picture 
(e.g., history, impairments in daily life, insight, and language 
problems) [20]. This view might change due to the accurate 
prediction of unsafe driving based on MMSE scores ≤ 19 in 
the current study. In this study, the group of patients with 
an MMSE ≤ 19 was rather small (n = 13) though; therefore, 
replication in a large sample of patients with AD is war-
ranted. If the finding is replicated, patients with AD with an 
MMSE ≤ 19 could be advised not to take the on-road driv-
ing assessment, but to adapt to alternative transportation. In 
conclusion, MMSE scores ≤ 19 clearly appear suspicious of 
unsafe driving, corresponding to high levels of sensitivity of 
the MMSE for moderate-to-severe levels of dementia [14, 
22]—stages of dementia, where driving is generally strongly 
discouraged [4, 20].
The possibility of using an upper MMSE cutoff (e.g., ≥ 
25) for the prediction of fitness to drive in patients with AD 
should be questioned. An accurate prediction of passing the 
on-road driving assessment for only 63% of the patients with 
AD with an MMSE score ≥ 25 is only slightly better than an 
estimation by chance (i.e., randomly guessing which 50% 
of patients with AD will pass the on-road driving assess-
ment). One should be very careful in arguing that it can be 
temporarily advised to drive for patients with AD based on 
an MMSE score ≥ 25, which was proposed by Versijpt and 
colleagues [7]. The MMSE is a short screening for global 
cognitive functioning, which may insufficiently cover sev-
eral cognitive domains that are highly relevant for driving, 
namely visuospatial abilities and executive functions [14, 
15, 23, 24]. Patients with cognitive impairments in these 
domains may be unsafe drivers, even when having high 
MMSE scores due to relatively preserved orientation and 
language functions. Consequently, a score above the upper 
MMSE cutoff should not be used as the sole indicator of 
fitness to drive in AD.
Other limitations of the MMSE include that scores are 
affected by age, education, and cultural background [14]. At 
high age (> 75–80 years), MMSE scores are usually lower 
risking an overestimation of the severity of cognitive impair-
ment. Furthermore, results of the MMSE should be inter-
preted with caution for patients with a very low education 
(e.g., patients who cannot read), as they might have a lower 
total MMSE score for this reason. At the other end of the 
spectrum, patients with a very high education may be able to 
mask their cognitive impairment and have high total MMSE 
scores despite cognitive impairments [14]. The MMSE is 
highly demanding on verbal functions; therefore, it is crucial 
that the patient understands and speaks the language well 
in which the MMSE is conducted. In conclusion, MMSE 
scores should never be interpreted on their own, but always 
in combination with at least demographic and further clini-
cal information about the patient with AD.
In the context of fitness to drive, the current results suggest 
that an MMSE score of 19 or lower might be sufficient reason 
to advise patients with AD to not drive until their fitness to 
drive is investigated further as these patients are likely to fail 
an on-road driving assessment. For exceptional patients with 
AD with an MMSE score ≤ 19 who are still safe to drive, the 
risk of premature driving cessation remains limited when the 
final decision is only made after thorough risk assessment. In 
contrast, the results of this study do not support the use of an 
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upper MMSE cutoff to state that it is temporarily allowable for 
patients with AD with high MMSE scores to continue driv-
ing, because many patients with AD with MMSE scores of 
25 and higher were unable to pass an on-road driving assess-
ment. The risk of advising continued unsafe driving appears 
to be high. This implicates that, even when MMSE scores are 
high, fitness to drive of patients with AD should be critically 
evaluated [18]. Even though pass rates on the on-road driving 
assessments of the three groups with high, intermediate, and 
low MMSE scores may be informative for patients with AD 
and their family members, an individual high MMSE score 
should not be used as the sole indicator of fitness to drive. To 
predict fitness to drive of patients with mild AD in a clinical 
setting, comprehensive fitness-to-drive assessments are neces-
sary [6, 11].
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